Leaders in the U.S. Senate aim to repeal one of the least popular provisions of the Patient Protection and Affordable Care Act: The 2.3 percent excise tax on manufacturers and importers of medical devices. 

The tax has been criticized by trade groups as costing jobs, and it appears to be falling well short of expectations in raising revenue.

Although a bipartisan coalition in the House of Representatives pushed through legislation in June to undo the tax, which is expected to bring in $30 billion over ten years, the bill will not become law until the Senate acts. But Democratic and Republican aides told the National Journal that the upper chamber will soon address the issue. 

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.